Alzheimer's Association Statement on Oral Semaglutide Phase 3 Topline Data Release
- Results Underscore Need for Continued Research and Diverse Treatment Pipeline CHICAGO, Nov. 24, 2025 /PRNewswire/ -- The Alzheimer's Association is disappointed that the evoke and evoke+ clinical trials did not demonstrate a statistically...
First Graphene Limited Announces Cement & Concrete Segment Update
Highlights Production of 600 tonnes of low carbon PureGRAPH® enhanced cement to go ahead in December targeting several client applications Concrete roof tiles containing PureGRAPH® enhanced cement to be trialed by specialist precast concrete...